precision medicine

infexn® is an advanced Next-Generation Sequencing (NGS)-based infectious disease diagnostic platform developed by HaystackAnalytics to help clinicians rapidly identify the cause of infections with greater accuracy than conventional diagnostic methods. Designed for hospitals and diagnostic laboratories, infexn® enables comprehensive detection of bacteria, fungi, major respiratory and neuropathic viruses, and antibiotic resistance genes (ARGs) from a single clinical sample, supporting faster and more informed treatment decisions.

identifi by HaystackAnalytics is a precision genomics platform offering advanced genetic testing powered by Next-Generation Sequencing (NGS). It provides genomic insights across areas such as inherited disorders, genetic health risks, cardiovascular conditions, pediatric health, and pharmacogenomics. By combining genomics, bioinformatics, and advanced sequencing technologies, identifi helps individuals and healthcare professionals better understand genetic factors that may influence health and medication response. The platform supports the growing adoption of personalized healthcare by translating complex genetic information into meaningful insights for informed healthcare decisions.